Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuhiko Azegami

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|October 14, 2015
The mucosal immune system: From dentistry to vaccine developmentHiroshi Kiyono, Tatsuhiko Azegami
International Journal of Hypertension|September 6, 2019
Vaccine Development against the Renin-Angiotensin System for the Treatment of HypertensionTatsuhiko Azegami, Hiroshi Itoh
International Immunology|June 11, 2014
Challenges in mucosal vaccines for the control of infectious diseasesTatsuhiko Azegami, Yoshikazu Yuki, Hiroshi Kiyono
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2011
[Angiotensin receptor vaccines]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 28, 2012
[Current status of vaccination therapy for hypertension]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Frontiers in Pediatrics|December 6, 2021
Blood Pressure Tracking From Childhood to AdulthoodTatsuhiko Azegami, Keiko Uchida, Mitsuaki Tokumura, et al.
Kidney Medicine|May 13, 2026
Pre-Dialysis Trajectory of Brain Natriuretic Peptide Levels and Body Weight in Chronic Kidney Disease Patients: A Predictive Marker for Unplanned Dialysis InitiationShinnosuke Sugihara, Takashin Nakayama, Tatsuhiko Azegami, et al.
Archivum Immunologiae Et Therapiae Experimentalis|July 17, 2014
Novel transgenic rice-based vaccinesTatsuhiko Azegami, Hiroshi Itoh, Hiroshi Kiyono, et al.
Kidney360|May 26, 2026
Clinical Relevance of Calcium Measures: QT-Based Comparison of Ionized, Total, and Albumin-Corrected CalciumHiroaki Miyauchi, Tatsuhiko Azegami, Takashin Nakayama, et al.
Journal of Atherosclerosis and Thrombosis|May 12, 2012
Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartanKaori Hayashi, Hiroyuki Sasamura, Tatsuhiko Azegami, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|October 14, 2015
The mucosal immune system: From dentistry to vaccine developmentHiroshi Kiyono, Tatsuhiko Azegami
International Journal of Hypertension|September 6, 2019
Vaccine Development against the Renin-Angiotensin System for the Treatment of HypertensionTatsuhiko Azegami, Hiroshi Itoh
International Immunology|June 11, 2014
Challenges in mucosal vaccines for the control of infectious diseasesTatsuhiko Azegami, Yoshikazu Yuki, Hiroshi Kiyono
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2011
[Angiotensin receptor vaccines]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 28, 2012
[Current status of vaccination therapy for hypertension]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Frontiers in Pediatrics|December 6, 2021
Blood Pressure Tracking From Childhood to AdulthoodTatsuhiko Azegami, Keiko Uchida, Mitsuaki Tokumura, et al.
Kidney Medicine|May 13, 2026
Pre-Dialysis Trajectory of Brain Natriuretic Peptide Levels and Body Weight in Chronic Kidney Disease Patients: A Predictive Marker for Unplanned Dialysis InitiationShinnosuke Sugihara, Takashin Nakayama, Tatsuhiko Azegami, et al.
Archivum Immunologiae Et Therapiae Experimentalis|July 17, 2014
Novel transgenic rice-based vaccinesTatsuhiko Azegami, Hiroshi Itoh, Hiroshi Kiyono, et al.
Kidney360|May 26, 2026
Clinical Relevance of Calcium Measures: QT-Based Comparison of Ionized, Total, and Albumin-Corrected CalciumHiroaki Miyauchi, Tatsuhiko Azegami, Takashin Nakayama, et al.
Journal of Atherosclerosis and Thrombosis|May 12, 2012
Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartanKaori Hayashi, Hiroyuki Sasamura, Tatsuhiko Azegami, et al.
Pageof 10